Home/nCage Therapeutics/Jonathan Heddle, Ph.D., D.Sc.

JH

Jonathan Heddle, Ph.D., D.Sc.

Chief Scientific Officer

nCage Therapeutics

Therapeutic Areas

Infectious Disease Oncology

nCage Therapeutics Pipeline

Drug	Indication	Phase
Synthetic VLP Vaccines	Respiratory Diseases	Pre-clinical
Antibody Drug Conjugates (ADCs)	Oncology	Pre-clinical

Leadership Team at nCage Therapeutics

John V. Bason, Ph.D.

Chief Operating Officer & Co-Founder

Christopher Kaplan

Chief Business Officer & Co-Founder

View full nCage Therapeutics profile